abnormal T cell physiology_Cdkn2c<tm1Yxi>/Cdkn2c<tm1Yxi>

http://metadb.riken.jp/0002444I129SvC57BL6DBA2Cdkn2ctm1YxiCdkn2ctm1YxiCdkn2ctm1Yxi

abnormal T cell physiology_Cdkn2c<tm1Yxi>/Cdkn2c<tm1Yxi>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
  http://metadb.riken.jp/db/mgi_rdf/MGI:105388

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cdkn2c<tm1Yxi>/Cdkn2c<tm1Yxi>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cdkn2c<tm1Yxi>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129/Sv * C57BL/6 * DBA/2

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal T cell physiology
  http://purl.obolibrary.org/obo/MP_0002444

文献

http://purl.org/net/cito/citesAsAuthority

• D S. Franklin, et.al., CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis., Genes & development, 1998, 12
  http://rdf.ncbi.nlm.nih.gov/pubmed/9744866